Search Results - "Ratusnu, N"

Fibrosis assessment in patients with nonalcoholic fatty liver disease: Adherence to proposed algorithms and barriers to complying with them by Marciano, S., Dirchwolf, M., Torres, M.C., Allevato, J., García Dans, C., García, B., Pollarsky, F., Gaite, L., Sirotinsky, E., Rios, B., Anselmo, M.N., Peche, M., Hurtado, E., Haddad, L., Narvaez, A., Mauro, E., Martinez, A., Bellizzi, C., Ratusnu, N., D’Amico, C., Arora, S., Gadano, A.

“…Fibrosis staging in patients with nonalcoholic fatty liver disease (NAFLD) is carried out through the application of stepwise algorithms but there is little…”
Get full text

Fibrosis assessment in patients with nonalcoholic fatty liver disease: Adherence to proposed algorithms and barriers to complying with them by Marciano, S, Dirchwolf, M, Torres, M C, Allevato, J, García Dans, C, García, B, Pollarsky, F, Gaite, L, Sirotinsky, E, Rios, B, Anselmo, M N, Peche, M, Hurtado, E, Haddad, L, Narvaez, A, Mauro, E, Martinez, A, Bellizzi, C, Ratusnu, N, D Amico, C, Arora, S, Gadano, A

“…Fibrosis staging in patients with nonalcoholic fatty liver disease (NAFLD) is carried out through the application of stepwise algorithms but there is little…”
Get full text

Access to direct-acting antivirals for the treatment of hepatitis C in a country with limited resources by Marciano, S, Haddad, L, Borzi, S M, D'Amico, C, Gaite, L A, Aubone, M V, Sirotinsky, M E, Ratusnu, N, Frola, M S, Aparicio, M C, Ríos, B, Anselmo, M N, Hansen, R, De Filippi, S, Dans, C García, de Labra, L, Peche, M A, Strella, T M, Ibáñez Duran, M, García Rosales, M B, Dirchwolf, M, Galdame, O A, Gadano, A C

“…To estimate the proportion of patients who access to direct-acting antivirals agents (DAAs) for the treatment of hepatitisC in Argentina and to evaluate…”
Get full text

Access to direct-acting antivirals for the treatment of hepatitis C in a country with limited resources by Marciano, S., Haddad, L., Borzi, S.M., D’Amico, C., Gaite, L.A., Aubone, M.V., Sirotinsky, M.E., Ratusnu, N., Frola, M.S., Aparicio, M.C., Ríos, B., Anselmo, M.N., Hansen, R., De Filippi, S., García Dans, C., de Labra, L., Peche, M.A., Strella, T.M., Ibáñez Duran, M., García Rosales, M.B., Dirchwolf, M., Galdame, O.A., Gadano, A.C.

“…To estimate the number of patients that have access to treatment of hepatitis C with direct-acting antivirals in Argentina and evaluate the factors associated…”
Get full text

Evaluación de fibrosis en pacientes con enfermedad por hígado graso no alcohólico: adherencia a los algoritmos propuestos y barreras para cumplir con ellos by Marciano, S., Dirchwolf, M., Torres, M.C., Allevato, J., García Dans, C., García, B., Pollarsky, F., Gaite, L., Sirotinsky, E., Rios, B., Anselmo, M.N., Peche, M., Hurtado, E., Haddad, L., Narvaez, A., Mauro, E., Martinez, A., Bellizzi, C., Ratusnu, N., D́Amico, C., Arora, S., Gadano, A.

“…La estadificación de la fibrosis en pacientes con enfermedad por hígado graso no alcohólico (EHGNA) se realiza aplicando distintos algoritmos. Sin embargo, hay…”
Get full text

Evaluación del acceso a antivirales para el tratamiento de la hepatitis C en un país con recursos limitados by Marciano, S, Haddad, L, Borzi, S.M, D’Amico, C, Gaite, L.A, Aubone, M.V, Sirotinsky, M.E, Ratusnu, N, Frola, M.S, Aparicio, M.C, Ríos, B, Anselmo, M.N, Hansen, R, De Filippi, S, Dans, C. García, de Labra, L, Peche, M.A, Strella, T.M, Ibáñez Duran, M, García Rosales, M.B, Dirchwolf, M, Galdame, O.A, Gadano, A.C

“…Resumen Objetivos Estimar la proporción de pacientes que acceden al tratamiento de la hepatitis C con antivirales de acción directa (AAD) en Argentina, y…”
Get full text

Treatment with direct‐acting antivirals for HCV decreases but does not eliminate the risk of hepatocellular carcinoma by Piñero, Federico, Mendizabal, Manuel, Ridruejo, Ezequiel, Herz Wolff, Fernando, Ameigeiras, Beatriz, Anders, Margarita, Schinoni, María Isabel, Reggiardo, Virginia, Palazzo, Ana, Videla, María, Alonso, Cristina, Santos, Luisa, Varón, Adriana, Figueroa, Sebastián, Vistarini, Cecilia, Adrover, Raúl, Fernández, Nora, Perez, Daniela, Tanno, Federico, Hernández, Nelia, Sixto, Marcela, Borzi, Silvia, Bruno, Andres, Cocozzella, Daniel, Soza, Alejandro, Descalzi, Valeria, Estepo, Claudio, Zerega, Alina, de Araujo, Alexandre, Cheinquer, Hugo, Silva, Marcelo, Ong, Janus

“…Background & Aims Data from Europe and North America have been published regarding the risk of developing hepatocellular carcinoma (HCC) after treatment with…”
Get full text

THU-337 - Safety and effectiveness comparing generic and original sofosbuvir-based treatment regimens in patients with hepatitis C: A prospective multicenter study from Argentina by Ridruejo, E., Mendizabal, M., Piñero, F., Alonso, C., Palazzo, A., Sixto, M., Ceballos, S., Gadea, C., Perez, D., Reggiardo, M.V., Moreno, V., Mengarelli, S.E., Bruno, A., Mendoza, C., Vila, J., Barreyro, F., Zuain, M.G.V., Ratusnu, N., Silva, M.

Get full text

Safety and effectiveness comparing generic and original sofosbuvir-based treatment regimens in patients with hepatitis C: A prospective multicenter study from Argentina by Ridruejo, E., Mendizabal, M., Piñero, F., Alonso, C., Palazzo, A., Sixto, M., Ceballos, S., Gadea, C., Perez, D., Reggiardo, M.V., Moreno, V., Mengarelli, S.E., Bruno, A., Mendoza, C., Vila, J., Barreyro, F., Zuain, M.G.V., Ratusnu, N., Silva, M.

Get full text